oppn parties Will Serum Institute Profiteer By Selling To States And Private Hospitals At The Stated Rates?

News Snippets

  • Calcutta HC says Cricket Association of Bengal is not liable to pay tax on advertisement inisde Eden Gardens cricket ground as it is not a 'public place' because it does not have unrestricted access for the general public
  • Supreme Court admits a plea from a child of a single OBC mother who had applied for an OBC certificate for her son
  • Supreme Court approves applying strict preventive detention laws for 'cybercriminals'
  • SBI likely to shift part of operations of its Global Market Unit from Kolkata to Mumbai
  • FM nirmala Sitharaman calls for a "structured, process-driven approach to compliance" and asks top I-T officials to speed up refunds and simplify processes
  • Marine insurance costs surge as the oil corridor in Strait of Homruz becomes risky due to war
  • Stocks weaken on Monday on global cues: sensex sheds 511 points to 81896 and Nifty 140 points to 24971
  • Former left-arm spinner Dilip Doshi dies in London at 77. He played for India in 33 Test matches and for Bengal in domestic tournaments
  • Pant becomes the only keeper to score two centuries in the same Test in England
  • England Test: Rishabh Pant hits his second ton and KL Rahul a classy century to put India on top, England need 350 runs on the last day, with the ptich showing signs of wear and tear
  • DGCA orders an audit of the entire aviation ecosystem in the wake of recent snags in many flights after the AI Dreamliner crash in Ahmedabad
  • 2 Pahalgam residents arrested by NIA for sheltering and aiding 3 terrorists who killed civilian tourists in pahalgam tell the agency that there were 3 LeT ultras from Pakistan that carried out the attack
  • India unlikely to agree to US demands for lower tariffs on agri products and GM food, trade deal faces fresh hurdles
  • Stocks likely to plummet today as traders will be worried about the effect of US strike on iran, oil price rise and possible inflation. Foreign funds may also withdraw in the volatile global situation
  • Oil prices likely to shoot up as US strikes at iran and the latter decides to close the Strait of Homruz
US President Donald Trump unilaterally announces a 'ceasefire' between Israel & Iran
oppn parties
Will Serum Institute Profiteer By Selling To States And Private Hospitals At The Stated Rates?

By Sunil Garodia
First publised on 2021-04-24 03:34:51

About the Author

Sunil Garodia Editor-in-Chief of indiacommentary.com. Current Affairs analyst and political commentator.

Indian Express has reported that Serum Institute is going to sell the Covishield vaccine (developed by Oxford University and AstraZeneca and being contract-manufactured in India by Serum) to private hospitals in India at the world's highest rate. It has made a rate chart (see lead picture) which shows that while the vaccine is available all over the world at between $ 2.15 (Rs. 162 in the European Union) to $5.25 (Rs. 395 in South Africa and Saudi Arabia). Serum has said that it will sell at Rs. 400 per dose to state governments and at Rs. 600 per dose to private hospitals. Although it had sold the first 100 million doses to the Central government at Rs. 150 per dose, Adar Poonawala, the CEO of Serum had stated at that time that the final price for private markets would be Rs.1000 per dose. Yet, the company had said that it was making a small profit even while selling to the Centre at Rs. 150 per dose.

So is Poonawala not the angel he first seemed when his company took a calculated gamble and produced the vaccine "at-risk" even before it was approved and supplied the shots immediately when they were approved at probably the cheapest rate in the world? Should he and Serum be allowed to get away with making huge profits by now supplying the shots at prices much higher than other countries pay, especially when the Centre has ploughed in Rs 3000 crore as advance payment for it to ramp up production? This is interest-free tax payers money Serum is getting and it should keep this in mind before fixing the rates for the shots.

India is a huge market. If Covishield can be supplied between Rs 162 and Rs 300 per dose in the European Union and UK, one feels that anything between that should be the rate at which Serum should supply to both the Centre and the states. It can charge a little extra for private hospitals. Ideally, the Centre should negotiate a combined rate for itself and the states and it should not be more than Rs. 250 per dose. Serum can then price the doses at Rs. 300 for private hospitals. Making profits is the right of all commercial entities and Serum should be allowed to make reasonable profits for its enterprise. But profiteering cannot be tolerated, not even in normal times let alone in a pandemic.